The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / October / AI Tools Target Eye Disease Mechanisms
Research & Innovations Latest News

AI Tools Target Eye Disease Mechanisms

Researchers secure $1.96 million NEI funding to develop computational tools that could identify key regulators of ocular health

10/30/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll
5 Key Takeaways
  • 1

    The National Eye Institute awarded the University of Texas at Arlington a $1.96 million grant for a 4-year project developing AI-powered tools to study ocular health and disease.

  • 2

    Led by Xinlei (Sherry) Wang with Lin Xu of UT Southwestern Medical Center, the project combines expertise in statistics, bioinformatics, omics, and ocular biology.

  • 3

    One tool will use scalable algorithms to analyze genomic datasets and identify transcriptional regulators associated with ocular health and disease.

  • 4

    A second tool will computationally separate cell-type signals in whole-tissue samples to investigate cell-specific regulatory activity without single-cell experiments for every regulator.

  • 5

    The researchers aim to integrate tissue-level and cell-type analyses to identify regulatory pathways for further study of eye disease mechanisms and potential diagnostic and therapeutic targets.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: